EMED workstations to debut at SCAR showEMED's efforts to compete for large-scale PACS installations will get a big boost at the Symposium for Computer Assisted Radiology in Rochester, MN, this month, where the San Antonio, TX-based vendor will
EMED's efforts to compete for large-scale PACS installations will get a big boost at the Symposium for Computer Assisted Radiology in Rochester, MN, this month, where the San Antonio, TX-based vendor will roll out its PACS Pro/DX primary diagnostic workstation. Shipments of the workstations, which have received Food and Drug Administration 510(k) clearance, are expected to begin in July.
The PACS PRO/DX primary diagnostic workstations will complement EMED's PACS PRO/DX viewstations, which are designed primarily for image review by clinicians, according to Manning Phillips, systems sales manager for the Midwest and New England.
The workstations will come in single or dual versions at resolutions of up to 2K x 2.5K. A quad-monitor setup offers resolutions of 1.2K x 1.6K or 1.7K x 2.3K. Both Windows NT and Unix-based workstations are available for the single- and dual-monitor configurations, while the quad-monitor setup comes only in a Windows NT version.
EMED underwent a restructuring last July that saw development of a Unix-based DICOM-compatible PACS PRO/DX workstation transferred to another division of EMED parent E-Systems in Garland, TX. That project has since been renamed PACS PRO II, and will include a server along with the workstation. PACS Pro II, also expected to be available around July, is optimized for centralized PACS environments, while the PACS PRO/DX primary diagnostic workstation is aimed at centralized reading applications that do not require the use of a server.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.